THE LOW CARB DIABETIC

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

Search found 1 match for NEJMDataSummit

Open-Data Momentum Builds; Trialist Resistance May Be Futile - Fri Apr 21 2017, 22:38

Background

In early April, the New England Journal of Medicine (NEJM) held a 1.5-day event in Boston called "Aligning Incentives for Sharing Clinical Trial Data" which was broadcast on the Web. Panels featured clinical trialists, data analysts, and patient participants—the three groups with interests in data—as well as government and funding agencies. To explore the potential benefits of data sharing ahead of the event, NEJM launched the SPRINT Data Analysis Challenge. The National Institutes of Health (NIH)- sponsored SPRINT trial compared intensive (≤120 mm Hg) versus standard blood pressure control in hypertensive patients at high cardiovascular risk. Challenge entrants were invited to analyze the dataset underlying the main publication and identify a novel finding that advances medical science. The three winners presented on day one of the webinar.
Watching the data summit online and following the Twittersphere (#NEJMDataSummit storified), data analysts and trial participants came across as open-data evangelicals, while clinical trialists who expressed concerns about misuse of data and lost career opportunities seemed like the "get off my lawn" old guard. Most trialists were not against the concept of data sharing but wanted an extended period of exclusive access and gatekeepers to control who got access as opposed to a more liberal free-for-all.

Medscape asked some attendees for feedback. Open-data proponent Atul Butte, MD, PhD (UCSF) emailed that he was optimistic and "saw a lot of change in attitudes during the summit." However, research-participant representative Sharon Terry (CEO, Genetic Alliance), who has two children with a rare disease, was "not surprised by the paternalistic, protectionist, conservative stance of the trialists" and "did not sense any transformation in their thinking."

More here http://www.medscape.com/viewarticle/878670


Back to top

Current date/time is Thu Mar 28 2024, 16:17